As we were on the topic of the slow nature of dealing with large pharmas, imo the company has a strategy that expansion of mix n go's uses into other industries will not occur in the researchable future. Considering the slow moving processes we all wait upon for confirmation of mix n go's acceptance and economic viability in diagnostics, whats to stop ADO marketing its product to other industries? most of which will not require the stringent goings-over of large pharmas.
any thoughts?
the current path
Add ADO (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
2.1¢ |
Change
-0.001(4.55%) |
Mkt cap ! $51.83M | |||
| Open | High | Low | Value | Volume |
| 2.2¢ | 2.2¢ | 2.1¢ | $14.69K | 692.2K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 1113604 | 2.1¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 2.2¢ | 180000 | 1 |
View Market Depth
| Last trade - 16.10pm 09/07/2024 (20 minute delay) ? |
| ADO (ASX) Chart |